Influence of molecular weight of carriers and processing parameters on the extrudability, drug release, and stability of fenofibrate formulations processed by hot-melt extrusion

Chokshi, 2010, Hot-melt extrusion technique: a review, Iran. J. Pharm. Res., 3 Shah, 2013, Melt extrusion with poorly soluble drugs, Int. J. Pharm., 453, 233, 10.1016/j.ijpharm.2012.11.001 Alshehri, 2015, Mefenamic acid taste-masked oral disintegrating tablets with enhanced solubility via molecular interaction produced by hot melt extrusion technology, J. Drug Deliv. Sci. Technol., 27, 18, 10.1016/j.jddst.2015.03.003 Patil, 2015, Hot-melt extrusion: from theory to application in pharmaceutical formulation, AAPS PharmSciTech, 1 Crowley, 2007, Pharmaceutical applications of hot-melt extrusion: part I, Drug Dev. Ind. Pharm., 33, 909, 10.1080/03639040701498759 Breitenbach, 2002, Melt extrusion: from process to drug delivery technology, Eur. J. Pharm. Biopharm., 54, 107, 10.1016/S0939-6411(02)00061-9 Liu, 2013, Use of polymer combinations in the preparation of solid dispersions of a thermally unstable drug by hot-melt extrusion, Acta Pharm. Sin. B, 3, 263, 10.1016/j.apsb.2013.06.007 DiNunzio, 2010, Fusion production of solid dispersions containing a heat-sensitive active ingredient by hot melt extrusion and Kinetisol® dispersing, Eur. J. Pharm. Biopharm., 74, 340, 10.1016/j.ejpb.2009.09.007 Kolter, 2012 Deng, 2013, Stabilization of fenofibrate in low molecular weight hydroxypropylcellulose matrices produced by hot-melt extrusion, Drug Dev. Ind. Pharm., 39, 290, 10.3109/03639045.2012.679280 Khougaz, 2000, Crystallization inhibition in solid dispersions of MK-0591 and poly (vinylpyrrolidone) polymers, J. Pharm. Sci., 89, 1325, 10.1002/1520-6017(200010)89:10<1325::AID-JPS10>3.0.CO;2-5 Kalivoda, 2012, Application of mixtures of polymeric carriers for dissolution enhancement of fenofibrate using hot-melt extrusion, Int. J. Pharm., 429, 58, 10.1016/j.ijpharm.2012.03.009 Zhou, 2002, Physical stability of amorphous pharmaceuticals: importance of configurational thermodynamic quantities and molecular mobility, J. Pharm. Sci., 91, 1863, 10.1002/jps.10169 Sanganwar, 2008, Dissolution-rate enhancement of fenofibrate by adsorption onto silica using supercritical carbon dioxide, Int. J. Pharm., 360, 213, 10.1016/j.ijpharm.2008.04.041 Lacroix, 1998, Fenofibrate raw materials: HPLC methods for assay and purity and an NMR method for purity, J. Pharm. Biomed. Anal., 18, 383, 10.1016/S0731-7085(98)00051-X Jamzad, 2006, Role of surfactant and pH on dissolution properties of fenofibrate and glipizide—a technical note, AAPS PharmSciTech, 7, E17, 10.1208/pt070233 Food and D. Administration, 2000 Bühler, 2008 Crowley, 2004, Physicochemical properties and mechanism of drug release from ethyl cellulose matrix tablets prepared by direct compression and hot-melt extrusion, Int. J. Pharm., 269, 509, 10.1016/j.ijpharm.2003.09.037 Qian, 2010, Drug–polymer solubility and miscibility: stability consideration and practical challenges in amorphous solid dispersion development, J. Pharm. Sci., 99, 2941, 10.1002/jps.22074 Alshahrani, 2015, Stability-enhanced hot-melt extruded amorphous solid dispersions via combinations of Soluplus® and HPMCAS-HF, AAPS PharmSciTech, 1